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h i g h l i g h t s
 We evaluate the removal of diclofenac in conventional water treatment processes.
 Aquat ic humic substances were used in the water of this study.
 The use of chlorine and chlorine dioxide as pre-oxidan t were investigated.
 Conventional treatment followed by activated carbon ﬁltration was also studied.
 Byproducts formed in the oxidation of diclofenac were identiﬁed by LC–MS/MS.a r t i c l e i n f o
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This study was carried out to eval uate the efﬁciency of conventional drinking water treatment processes 
with and wit hout pre-oxidation with chlorine and chlorine dioxide and the use of granular activated car- 
bon (GAC) ﬁltration for the removal of diclofenac (DCF). Water treatment was performed using the Jar 
test with ﬁlters on a lab scale, employing nonchlorinated artesian well water prepared with aquatic 
humic substances to yield 20 HU true color, kaolin turbidity of 70 NTU and 1 mg L1 DCF. For the quan- 
tiﬁcation of DCF in water samples, solid phase extraction and HPLC–DAD methods were developed and 
validated . There was no removal of DCF in coagulation with aluminum sulfate (3.47 mg Al L1 and
pH = 6.5), ﬂocculation, sedimentation and sand ﬁltration. In the treatment with pre-oxidation and disin- 
fection, DCF was partially removed, but the concentration of dissolved organic carbon (DOC) was 
unchan ged and byproducts of DCF were observed. Chlorine dioxide was more effective than chorine in
oxidizing DCF. In conclusion, the identiﬁcation of DCF and DOC in ﬁnished water indicated the incom- 
plete elimination of DCF through conventional treatments. Nevertheless, conventional drinking water 
treatment followed by GAC ﬁltration was effective in removing DCF (P99.7%). In the oxidation with chlo- 
rine, three byproducts were tentatively identiﬁed, corresponding to a hydroxylation, aromatic substitu- 
tion of one hydrogen by chlorine and a decarboxylation/hydroxylation. Oxidation with chlorine dioxide 
resulted in only one byproduct (hydroxylation).
 2013 Elsevier Ltd. All rights reserved.1. Introduction The presence of pharmaceutical residues in efﬂuents from The occurrence and fate of pharmac eutical compounds and 
their metabolites in the aquatic environm ent have been recognized 
as an emerging issue. There is concern because little is known 
regarding the potential effects of these compounds on non-target 
organisms, mainly chronic toxicity and possible additive effects 
of a vast range of pharmaceutical s present in the aquatic environ- 
ment, even at trace levels (ng L1 or lg L1) (Huang et al., 2011;
Rodil et al., 2012 ).wastewa ter treatment plants (WWTPs) shows that not all pharma- 
ceuticals are completely removed during treatment (Zhang et al.,
2008; Morasch et al., 2010; Rodil et al., 2012 ). Consequently, they 
have been widely found at concentratio ns in the ng L1–lg L1
range in surface waters, which is the main source of raw water 
in drinking water treatment plants (DWTPs) (Vieno et al., 2007;
Vulliet et al., 2011; Montagner and Jardim, 2011; Valcárcel et al.,
2011a,b) and groundwate r (Lapworth et al., 2012 ). Due to their 
inefﬁcient treatment in DWTPs and their hydrophi lic propertie s,
a number of pharmaceuti cals have also been found in drinking 
water at concentratio ns in the order of ng L1 (Ziylan and Ince,
2011; Vulliet et al., 2011; Valcárcel et al., 2011a,b; Rodil et al.,
2012).
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drugs frequent ly found in aquatic environm ents are aspirin, acet- 
aminophen, ibuprofen , naproxen and diclofena c (DCF) (Fent et al.,
2006). The DCF has been found in drinking water at concentra- 
tions <10 ng L1 (Rabiet et al., 2006; Vulliet et al., 2011 ).
Although the pharmaceuti cals are still not regulated in drinking 
water, it is of great importance to know if the treatments applied to
DWTPs can eliminate pharmac eutical compound s. Moreover, little 
is known about the occurrence and fate of byproducts (metabolites
and transformat ion products) formed during drinking water treat- 
ments and their (eco)toxicological effects (Touraud et al., 2011 ).
Research on the possible byproducts formed through the biodegra- 
dation and chlorination of some pharmac euticals during treat- 
ments at WWTPs and DWTPs has been reported (Quintana et al.,
2005, 2010; Soufan et al., 2012 ). However, no study has reported 
on the byproducts of DCF formed by oxidation with chlorine 
dioxide.
Conventional treatments have been reported ineffective in the 
removal of most pharmaceutical s, with an efﬁciency of <5–40%
(Vieno et al., 2007; Pojana et al., 2011 ). However, processes and unit 
operations, such as ozonation (Ikehata et al., 2006 ), adsorption on
activated carbon (Kim et al., 2007 ) and membran e ﬁltration, such 
as nanoﬁltration and reverse osmosis (Radjenovic et al., 2008;
Boleda et al., 2011 ), have shown effective in the removal of a rela- 
tively large number of pharmaceutical s (>99%). In general, the 
percentage removed depends on several factors, such as molecular 
structure of pharmaceutical s, type and dosage of coagulant,
presence and characteri stics of dissolved organic matter (DOM),
mechanism of coagulation and experimental conditions (Vieno
et al., 2007; Pojana et al., 2011 ). Nevertheles s, the use of advanced 
processes in DWTPs is still limited due to their high cost, especially 
in developing countries , as Brazil.
Most studies on the removal of pharmaceutical s have focused on
a small set of processes or operations of water treatment. Moreover,
they have used humic substances extracted from peat instead of
water, which have different characteri stics, including a lower con- 
tent of humic acids than fulvic acids, molecule s of lower molecular 
weight and less condensed structures, which may hinder the re- 
moval of pharmaceuti cals (Rigobello et al., 2011 ).
This study was carried out to evaluate the efﬁciency of conven- 
tional drinking water treatment processes (coagulation, ﬂoccula-
tion, sedimentati on, sand ﬁltration and chlorine disinfection)
combined with pre-oxidation using chlorine and chlorine dioxide 
and adsorption on granular activated carbon (GAC) in the removal 
of DCF in water containing aquatic humic substances (AHSs). Addi- 
tionally, the byproducts formed during the oxidation of DCF with 
chlorine and chlorine dioxide were tentatively identiﬁed by
LC–MS/MS. The selection of the analyte DCF was based on its high 
consumptio n, high frequenc y of detection in the aquatic environ- 
ment and low biodegradab ility and polarity, which favor its spread 
in natural waters (Vieno et al., 2007; Zhang et al., 2008 ).2. Materials and methods 
2.1. Chemicals and reagents 
Acetonitrile and methanol were of HPLC grade (Baker) and high- 
purity water was obtained from a Milli-Q water system (Millipore)
equipped with a UV radiation source. The coagulan t used was a com- 
mercial liquid of aluminum sulfate (Al2(SO4)314.3H2O, 50%, w/w)
containing 7.3% Al2O3 (w/w) with speciﬁc density of 1.3 g cm3 and
3.85%aluminum (w/w). The chlorine dioxide solution (300 mg ClO 2 -
L1) generated from the sodium chlorate was supplied by Eka Chem- 
icals SA of Brazil – Akzo Nobel Company. The chlorine solution was 
prepared from a solution of sodium hypochlorite with 12.9% active chlorine and 1.22 g cm3 density provided by the DWTP of São Carlos 
– SP, Brazil. The solutions of chlorine and chlorine dioxide were pre- 
pared at the desired concentrations by dilution with water (Milli-Q
system, 18.2 MX cm at 25 C). The analytical standard of DCF 
(sodiumsalt,CAS number 15307-79- 6)had >99%purity and was sup- 
plied by Sigma–Aldrich. DCF has a Kow of 4.51 and a pKa of 4.15 (Vieno
et al., 2007 ). A stock solution of DCF was prepared in methanol at a
concentr ation of 200 mg L1 and stored in a refrigerator at 4 C.
2.2. Water sample collection and extraction of AHS 
The AHS used to adjust the color of the synthetic water samples 
were extracted from the water collected in a tributary of the Itapa- 
nhaú River (Latitude 2347019,3500 S and Longitude 463029,3200 W)
in Bertioga, São Paulo, Brazil (tropical forest). The AHS were isolated 
by adsorption chromatogr aphy on XAD-8 non-ionic macroporou s
resin (Supelco) according to the method of Thurman and Malcolm 
(1981). The water samples collected exhibited a true color of 184 
HU, turbidity of 4.38 NTU, pH = 4.9, dissolved organic carbon 
(DOC) of 17.4 mg C L1, alkalinity of 6 mg CaCO 3 L1 and UV absor- 
bance at a wavelength of 254 nm (UV254) of 4.79. Overall, character- 
ization results indicated that the AHS fraction contained a greater 
aliphatic than aromatic carbon content and a relatively high per- 
centage of oxygen atoms (higher content of fulvic acids than humic 
acids). The AHS were characterized as described by Rigobello et al.
(2011).
2.3. Analytica l methods 
The turbidity of the samples was measured using a HACH 2100P 
turbidity meter. A Shimadz u 5000A total organic carbon (TOC) ana- 
lyzer spectrophot ometer was used to determine the DOC content 
in the water samples. UV254 and color were measured by a HACH 
DR4000 spectrophot ometer at 254 and 455 nm, respectively . All 
samples were ﬁltered through a 0.45 lm membran e (Millipore,
cellulose ester, 90 mm diameter) prior to both UV254 and UV278,
DCF and DOC analyses to remove particles. The pH of the water 
samples was measured using an Orion 420A potentiometer. The 
chlorite ion present in the water samples after the pre-oxidation 
with chlorine dioxide was determined by a colorimetric method 
with a Prominent DT4 instrument. The UV/Vis analysis was 
performed using a UV/Vis JASCO – 630 V spectrophot ometer. The 
concentr ations of Cl2 and ClO 2 were quantiﬁed by reaction with 
N,N-dieth yl-p-phenylene diamine (DPD) using a HACH DR4000 
spectrophot ometer at 530 nm. The analysis of ClO 2 with DPD was 
performed according to the manufactur er’s instructions.
2.3.1. HPLC-DAD analysis 
The DCF was extracted from the water samples using solid 
phase extraction (SPE) with Phenomex C18 sorbent (6 mL;
500 mg of resin weight). Each C18 sorbent was pre-conditio ned 
with 5 mL of methano l and 5 mL of puriﬁed water (Milli-Q) at a
ﬂow rate of 2 mL min 1. Next, 100 mL of water (pH between 6.0 
and 8.0) was passed through the C18 sorbent at a ﬂow rate of
5 mL min 1. The DCF was eluted with 5 mL of methano l in a volu- 
metric ﬂask. The samples were then analyzed on an HPLC coupled 
to a DAD detector operating at k = 278 ± 4 nm (Agilent Technolo -
gies) with an autosamp ler using a Zorbax C18 (250 mm  4.6 mm
id  5 lm particles ) column. The ﬂow rate was 0.8 mL min 1, the 
injection volume was 20 lL, the column oven was set to 25 C
and the retention time was 10 min. An isocratic mobile phase of
acetonitri le:water (65:35, v/v) was used and both components 
were acidiﬁed with 0.05% triﬂuoroacetic acid (99.9% purity).
The method employed was validated according to resolution 
number 899 of the National Agency of Sanitary Vigilance (ANVISA,
2003). The limit of quantiﬁcation (LOQ) was 3 lg L1 and the limit 
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plied to determine DCF concentratio ns in the water samples ranging 
from 3 to 1200 lg L1. The correlation coefﬁcients (r) were >0.99,
the relative standard deviation s <15% and the accuracy between 
96% and 108% for both curves. The mean intra- and inter-day repro- 
ducibility ranged from 96% to 101%, the relative standard deviations 
were below 15%, the recovery of the DCF concentr ations ranged 
from 94% to 101% and the accuracy from 97% to 107% through three 
spiking levels in synthetic water: 3, 500 and 1000 lg DCF L1. Sam- 
ples with known concentratio ns of DCF were prepared in puriﬁed
water (Milli-Q) and in synthetic water (containing AHS and kaolin)
to examine the speciﬁcity of the method. The organic matrix did not 
interfere with the analyte detection.
2.3.2. LC–MS/MS (ion trap)
For the separation and identiﬁcation of the byproducts of DCF 
formed in the oxidation with chlorine and chlorine dioxide, SPE was 
employed as described previously. This extractio n was followed by
LC using HPLC SHIMADZU LC-20A and an autoinjector with a UV
detector coupled to a spectrometer mass (MS) and an ion trap ana- 
lyzer (Bruker).The chromatogr aphic separation was performed asde- 
scribed for the HPLC–DAD analysis, but the mobile phase was not 
acidiﬁed and the injected sample volume was 50 lL.
The ionization of the compound s was achieved by electrospray 
in negative mode and quasi-mol ecular ions were detected from the 
loss of a proton, characterized as [M–H]. An initial analysis in MS
mode was performed over a full scan to detect compounds and 
fragmentation experiments were performed to conﬁrm the com- 
pounds detected.
2.4. Preparation of synthetic water 
Nonchlorina ted water extracted from an artesian well (turbid-
ity = <0.2 NTU; apparent color = <2 HU; pH = 6.2; alumi- 
num = <0.01 mg Al L1; DCF = not detected) was used to prepare 
synthetic water with AHS to yield 20 ± 1 HU true color and kaolin to
yield turbidity of 70 ± 2 NTU (typical characteri stics during the rainy 
season in the region of São Carlos, São Paulo, Brazil) and spiked with 
1 mg L1 DCF (sodiumsalt,Sigma–Aldrich,purity >99%).The concen- 
tration ofDCF was based onthe LOQ ofthe method.The water samples 
were stored for up to1 week atroom temperature . The resulting alka- 
linity was between 22 and 23 mg CaCO 3 L1. The absorbance mea- 
surements and DOC were performed using water samples ﬁltered
through a 0.45 lm membran e of cellulose acetate. Absorbance and 
pH measureme nts were performed without adding sodium thiosul- 
fate to the samples.
2.5. Water treatment tests 
Conventional water treatment tests were carried out using the 
Jar test (ETICA) with six square beakers (2 L), which provided veloc- 
ity gradients in the 10–1200 s1 range and two kits of six bench- 
scale ﬁlter columns with internal diameters of 19 mm in series.
Six ﬁlters were ﬁlled with a 15 cm layer of sand, and the other six 
ﬁlters were ﬁlled with a 15 cm layer of GAC, both with grain sizes 
ranging from 0.30 to 0.59 mm. The following paramete rs were 
adopted for the tests: rapid mixing (time = 10 s; velocity gradient 
rapid mixing = 1000 s1), ﬂocculation (time = 20 min; velocity gra- 
dient ﬂocculation = 15 s1), sedimentation (velocity = 1 cm min 1),
ﬁltration rate (sand/GAC ﬁlters = 60 m3 m2 d1), ﬁltration time 
after sedimentati on (sand/GAC ﬁlters = 20 min) and empty bed con- 
tact time (sand/GAC ﬁlters = approximat ely 3.6 min). The tempera- 
ture of the water during the Jar test trials was kept at approximat ely 
20 C. The sand ﬁlters were conditioned with deionized water prior 
to passing settled decanted water through them and were cleaned after each different experime ntal test trial with tap water in ascen- 
dant ﬂow for 10 min.
Extensive Jar testing for coagulation, ﬂocculation and sedimenta- 
tion (22 Jar tests with six jars) were conducte d to deﬁne the zones of
optimum turbidity removal in settled water to 65 NTU, for water 
samples without DCF. A solution of NaOH was used prior to the 
addition of aluminum sulfate to vary the coagulation pH.
After ﬁnding the optimum zone for the removal of turbidity 
(65 NTU) in settled water by coagulation , ﬂocculation and sedi- 
mentation, three aluminum doses (3.5, 4.2 and 5.0 mg Al L1) and 
coagulation pH values (6.5, 6.7 and 6.6, respectively ) were chosen 
based on the lowest turbidity values (1.8 ± 0.1 NTU) and color 
(10 ± 1 HU). This selection was performed to evaluate the removal 
of DOC, DCF and minimize residual aluminum by coagulation , ﬂoc-
culation, sedimentation and sand ﬁltration.
Because there was no difference in the removal of DOC and DCF 
for the three doses of coagulan t, an aluminum dose and coagulation 
pH (3.46 mg Al L1 and pH 6.5) were selected based on the lowest 
concentr ation of residual aluminum (60.1 mg L1), color, turbidity 
of the ﬁltrated water and lowest doses of NaOH and coagulant 
required.
Following sand and GAC ﬁltration, the water was disinfected by
adding sodium hypochlo rite at 5 mg Cl2 L1. The contact time for 
disinfecti on was 30 min and 24 h. In the experiments, 250 mL of
water were used in a capped amber vial under constant agitation 
(100 rpm) at 20 C. This test was performed in duplicate for each 
contact time. The chlorine reaction was stopped by the addition 
of sodium thiosulfa te.
The doses of chlorine and chlorine dioxide used in the pre-oxida- 
tion were selected based on the residual oxidant concentration 
(approximately 0.1 mg L1) to avoid interference with the adsorp- 
tion of DCF on GAC. Typically, 50–70% of the chlorine dioxide ap- 
plied becomes chlorite ions, which limits the dosage of this 
oxidant in DWTPs to, at most, 1.4 mg L1 and the total combined 
dioxide chlorine, chlorite and chlorate to 1 mg L1 (USEPA, 1999 ).
In Brazil, Ordinance n. 518/2004 of the Health Ministry (URL,
Ministry of Health, 2004 ) was repealed and has recently reemerge d
as Ordinance 2914 of December 2011, changing the maximum 
amount of chlorite in treated water from 0.2 to 1.0 mg L1 (URL,
Ministry of Health, 2011 ). Therefore, the chlorine dioxide dose cho- 
sen for the pre-oxidation was smaller than or equal to 0.2 mg chlo- 
rite L1 because Ordinance 518/2004 (URL, Ministry of Health,
2004) was in force during this study. The doses of the oxidants se- 
lected and contact times for the pre-oxidation followed by conven- 
tional treatment and adsorption on GAC were: 0.25 mg ClO 2 L1
with contact time of 30 min and 1 mg Cl2 L1 with contact time of
1 h. The coagulation pH was adjusted using a NaOH solution.
The GAC used was produced from the babaçu coconut shell 
(Tobasa, Brazil) with 957 mg g1 I2, density of 0.452 g cm3, 7.0%
humidity and particle size between 0.30 and 0.59 mm. The isotherm 
was evaluated on a logarithmi c scale accordin g to the Freundlich 
isotherm (ASTM Standards: D 3860-98). The value of KF was equal 
to 79 and 1/n was equal to 0.16. The linear coefﬁcient was 0.94.
GAC ﬁltration was performed after the sand ﬁltration.2.6. DCF oxidation experiments for the identiﬁcation of byproducts 
DCF oxidation experiments were performed with 250 mL of puri- 
ﬁed water (Milli-Q) at pH 6.0 and spiked with 1 mg L1 DCF for the 
identiﬁcation of byproducts. The doses of chlorine and chlorine 
dioxide were 5 mg Cl2 L1 and 1.4 mg ClO 2 L1, respectively. Parallel 
control samples (without DCF) were also studied. After 24 h, the 
reactions were quenched with ascorbic acid (0.5 mg mL1) and 
two 100 mL aliquots of this solution were extracted by SPE and ana- 
lyzed by LC–UV and MS, as previously described .
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3.1. DCF removal through treatment processes 
The results of the parameters analyzed in the synthetic water 
with DCF and after conventi onal treatment with and without 
pre-oxidation with chlorine and chlorine dioxide and GAC ﬁltration
are shown in Table 1 and Figs. 1–3 for the optimized aluminum 
dose and coagulation pH (3.5 mg Al L1 and pH 6.5).
Table 1 shows that the synthetic water without DCF (blank) had 
low content of DOC, absorbance at 254 and 278 nm and no DCF de- 
tected by HPLC–DAD.
The results of the bench-scale tests with synthetic water with- 
out DCF (DOC range 5.7–5.9 mg L1) showed that the removal of
DOC was very low in the sand ﬁltration (approximately 
1.5 mg L1), whereas the removal of color (<1 HU) and turbidity 0
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. 1. HPLC-DAD chromatograms of water samples after conventional drinking 
ter treatment processes: (a) without pre-oxidation followed by GAC ﬁltration;
with pre-oxidation with chlorine (POCl2) followed by GAC ﬁltration and 
infection and (c) with pre-oxidation with chlorine dioxide (POClO2) followed by
C ﬁltration and disinfection.
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188 E.S. Rigobello et al. / Chemosphere 92 (2013) 184–191(<0.50 NTU) were high. However, the removal of DOC was high on
GAC ﬁltration (approximately 4.5 mg L1).3.1.1. Conventiona l treatment without pre-oxidation followed by GAC 
ﬁltration
Table 1 shows that even under optimized conditions of color re- 
moval (10 ± 1 HU) and turbidity (1.8 ± 0.1 NTU), the conventional 
treatment (coagulation with 3.5 mg Al L1 and pH 6.5, ﬂocculation,
sedimentation and sand ﬁltration) was not effective in removing 
DCF because no signiﬁcant differenc e was found between the con- 
centration of DCF in the synthetic water (1024 lg L1) and that 
after sand ﬁltration (1033 lg L1). This differenc e was approxi- 
mately 1% and the accuracy values were 102% (synthetic water)
and 103% (sand-ﬁltered water), which are in the 85–115% range 
accepted by most regulator y bodies for the chromatogr aphic anal- 
ysis of pharmaceutical s (ICH, 1995; ANVISA, 2003 ). However, the 
conventional treatment was effective in removing color and tur- 
bidity (sand-ﬁltered water with apparent color 61 HU and turbid- 400
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Fig. 3. Removal of DCF in different stages of conventional drinking water treatment withity 60.50 NTU). These results are in agreement with those reported 
in the literature, which refer to a reduction in the concentration of
DCF to less than 5% by coagulation with aluminum sulfate, ﬂoccu-
lation, sedimentati on and sand ﬁltration (Vieno et al., 2010 ). In
general, these processes are not efﬁcient in removing the majority 
of pharmaceutical s from water (Kim et al., 2007; Pojana et al.,
2011). In Ternes et al. (2002), the ineffectiven ess of sand ﬁltration
was linked to the poor adsorptio n of the hydrophi lic drug on the 
surface of sand.
According to the literature data, the removal of pharmac euticals 
by coagulation is inﬂuenced mainly by the type and dose of coag- 
ulant, the presence and characteristics of the DOM, particularly 
humic substances, the coagulation pH, the coagulation mechanis m
and the molecular structure of the compounds to be removed (Vie-
no et al., 2010 ).
After the disinfection of the sand-ﬁltered water for 30 min and 
24 h of contact time, approximat ely 50% of the initial dose of chlo- 
rine were consumed and the concentration of DCF was reduced 5
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Fig. 4. Mass spectra (LC–MS) and proposed chemical structure of DCF and byproducts after oxidation with chlorine and chlorine dioxide.
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(Table 1). Chlorine proved to be an effective oxidant for removing 
DCF (under the conditions studied), but because the concentratio n
of DOC remained virtually the same as in the synthetic water 
(Fig. 2), the DCF was not mineralized and byproducts were formed.
The oxidation of DCF by chlorine generated several byproducts 
(M1, M2, M3 and M4), as indicated by HPLC–DAD (Fig. 1a). Several 
of these byproducts were tentatively identiﬁed by LC/MS/MS in
samples after oxidation with chlorine (24 h) in puriﬁed water 
(Milli-Q), which led to the proposed structure s shown in Fig. 4.
In the LC–MS chromatogr am of oxidized puriﬁed water, a peak 
before DCF at 4.1 min was identiﬁed and its MS spectrum revealed 
a molecular ion at m/z 310 Da and two additional ion fragments at
m/z 266 and 230 (Fig. 4b). This molecular ion corresponded to the 
addition of oxygen and loss of hydrogen. The MS/MS fragmentation 
spectrum of m/z 310 showed a fragment ion at m/z 266 (loss of
CO2), and the MS3 fragmentation spectrum of m/z 266 showed a
fragment ion at m/z 230 (loss of HCl). The difference in mass 
between the molecular ion of the product (310 Da) and DCF 
(294 Da) was 16 Da, which might be related to the hydroxylation 
of the compound. The addition of a hydroxyl to the molecule 
supported the lower retention time observed for the compound 
by increasing the molecule ’s polarity. This byproduct of m/z
310 Da was not identiﬁed by Quintana et al. (2010).
Other peaks at 6 and 7.2 min were obtained by LC–MS. A
molecular ion at m/z 328 Da and two additional ion fragments at
m/z 284 and 248 were revealed in the MS spectrum shown in
Fig. 4c. Another molecular ion at m/z 300 Da and one ion fragment 
at m/z 161 were tentatively identiﬁed in the MS spectrum (Fig. 4d).
These structure s are in agreement with the MS/MS and MS3
fragmentation s identiﬁed and are similar to those observed by
Quintana et al. (2010). The difference in mass between the compound at m/z 328 Da and DCF at m/z 294 Da (Fig. 4c) corre- 
spond to a chlorine (34 Da), which represent substitut ion of a
hydrogen by a chlorine atom on DCF. The product ion at m/z
300 Da (Fig. 4d) is believed to have been formed through a lactone 
intermedi ate by the decarboxylati on and oxidation of the dichlori- 
nated ring at position 4, following a mechanism similar to that de- 
scribed by Miyamoto et al. (1997) in the metabolic HClO oxidation 
of DCF. Conversely, no CO2 loss was observed for the m/z 328 Da
ion (i.e., there was no carboxylic acid group in the structure).
However , there was a CO loss (typical for alcohols) and a fragment 
at m/z 161 Da, correspond ing to the dichlorinated phenolate anion 
(C6H3OCl2), the resulting product was hydroxylated at position 4 of
the dichlorin ated benzene ring. The investigatio n of the (eco)toxi-
cological effects of these byproducts and DCF in drinking water in
future research is thus required.
The reaction of chlorine with organic compounds occurs mainly 
by addition and substitution , usually at hydrogen positions. The 
oxidation with chlorine occurs primarily at sites rich in electrons,
such as in unsaturated compound s (double or triple bonds) and 
in aromatic rings activated with hydroxyl groups and amines 
(Bedding et al., 1983 ).
The GAC was qualitatively efﬁcient in removing DCF, as indi- 
cated by zero absorbance at 278 nm (k max DCF) and low concen- 
trations of DOC, and no DCF was detected in the chromatogr am
obtained by HPLC–DAD (Table 1 and Fig. 1a). Because the LOQ of
the method was 3 lg L1, the removal of DCF in GAC was greater 
than or equal to 99.7%.
3.1.2. Conventional treatment with pre-oxidation (chlorine and 
chlorine dioxide) followed by CAG ﬁltration
The absorbance values at 254 and 278 nm and the DOC of both 
sand-ﬁltered water (for both pre-oxidants) and synthetic water 
190 E.S. Rigobello et al. / Chemosphere 92 (2013) 184–191(Table 1) were nearly identical, indicating the poor efﬁciency of
these treatment steps in the removal of AHS and DCF.
Because the measured concentration ofDCF inthe synthetic water 
was 1013 lg L1, the DCF removal was approximat ely 15% after pre- 
oxidation with chlorine (1 mg Cl2 L1/1 h), coagulation , ﬂocculation,
sedimentation and sand ﬁltration. When the pre-oxidati on was per- 
formed with chlorine dioxide (0.25 ClO 2 mg L1/30 min), the DCF 
removal was approximately 25% (Table 1 and Fig. 3). Thus, chlorine 
dioxide was more effective than chlorine in removing DCF. However ,
toefﬁciently remove DCF from synthetic water, it would benecessary 
to use a higher dose of oxidant and longer contact time. This was not 
done to not exceed the limits of residual oxidant and chlorite estab- 
lished byregulator yagencies and also due tothe possible interference 
of these compounds during the adsorption of DCF on GAC.
Fig. 1b shows the overlapped chromatogram s obtained by
HPLC–DAD of the synthetic water, sand-ﬁltered water (after con- 
ventional treatment with pre-oxidation with chlorine), water ﬁl-
tered on GAC and after disinfection of the water ﬁltered on GAC.
A reduction in the height of the chromatographi c peak for DCF in
the sand-ﬁltered water in comparison with the synthetic water 
and possible formation of byproducts of DCF due to chlorine oxida- 
tion were observed. These byproducts were observed as peaks in
the chromatogram at approximat ely 4 min and between 5.5 and 
6.5 min.
As shown in Figs. 1b, c and 3, DCF was not detected (up to
2 lg L1) in the water after GAC ﬁltration (pre-treatment with both 
pre-oxidant s) and after disinfection of GAC-ﬁltered water, demon- 
strating that the GAC used was effective in the removal of DCF 
(P99.7%). Other indications of the absence of DCF after CAG ﬁltra-
tion were the zero absorbance at 278 nm and low concentr ations of
DOC (Table 1).
Fig. 1c shows a minor peak area for DCF was observed in the 
sand-ﬁltered water in comparison with the synthetic water (pre-
oxidized with chlorine dioxide). Nevertheless, the presence of a
peak near at 4 min was clear, indicating the presence of a byprod- 
uct. A byproduct with a molecular ion of m/z 310 Da (C14H9O3NCl2)
was identiﬁed by LC–MS/MS (Fig. 4b), representi ng the introduc- 
tion of an oxygen atom and the loss of two hydrogen atoms. Frag- 
ment ions at m/z 266 (C13H9OCl2N) for the loss of CO2 and at m/z
230 (C13H8OClN) for the loss of HCl were also observed . The 
byproduct of m/z 310 Da correspond ed to the addition of a hydro- 
xyl to the nonchlorinated ring of DCF (Fig. 4b).
Chlorine dioxide has a lower oxidation potential than that of
ozone and a greater potential than the potential s of chlorine and 
chloramines (Huber et al., 2005 ). Oxidant alternatives to chlorine,
such as chlorine dioxide, are indicated when there is a high con- 
centration of precursors (DOM, algae, bromides and cyanobacter ia)
to avoid the formation of halogenated byproducts in water, such 
trihalometh anes (Muttama ra et al., 1995 ).
However, chlorine dioxide can produce aldehydes and carbox- 
ylic acids in the presence of DOM (Da˛browska et al., 2005 ), as well 
as inorganic byproducts , such as chlorite and chlorate, which are 
considered harmful to human health (Steffen and Wetzel, 1993 ).
With respect to organic compounds, chlorine dioxide presents a
strong reactivity for phenols, neutral tertiary amines and certain 
polyaromati c compounds (Hoigné and Bader, 1994 ).
In most cases, the use of chlorine and chlorine dioxide oxidants 
does not promote the complete mineralization of pharmaceuti cals 
to CO2, but leads the formation of a wide variety of byproducts 
(Melo et al., 2009 ).4. Conclusions 
Under the optimal conditions for the removal of turbidity and col- 
or, the conventional treatment comprising coagulation with alumi- num sulfate (3.46 mg L1 of aluminum and pH 6.50), ﬂocculation,
sedimentati on and sand ﬁltration did not remove DCF.
In the pre-oxidation with chlorine (Cl2 mg L1/1 h) followed by
coagulation , ﬂocculation, sedimentation and sand ﬁltration
approximat ely 15% of DCF removal was obtained, whereas with 
chlorine dioxide oxidant (ClO2 0.25 mg L1/30 min) the removal 
was approximately 25%. Comparing the two pre-oxidant s, chlorine 
dioxide was considered the stronger oxidant and was more effec- 
tive than chlorine in reducing DCF.
In the disinfection (chlorination) of sand-ﬁltered water (con-
ventiona l treatment without pre-oxidation), DCF was reduced by
approximat ely 35 and 97% for contact times of 30 min and 24 h,
respectivel y. Under the studied condition s, chlorine was shown 
to be an effective oxidant in the removal of DCF. However, because 
the concentration of DOC obtained was approximately the same as
that in the synthetic water, the mineralization of DCF was incom- 
plete and byproducts were formed.
Among the stages of treatment studied, adsorption on GAC re- 
sulted in the most signiﬁcant removal of DCF. Accordingl y, DCF was 
not detected in water samples after this stage (LOD = 2 lg L1). Con- 
sidering that the LOQ of the method was 3 lg L1, at least 99.7% of the 
DCF was removed byGAC.Because the rupture curves ofGAC were not 
studied, the results of GAC can be considered qualitative. However , to
investiga te the removal of DCF in ﬁeld-scale water treatment plants,
the method must be improved to achieve lower detection limit (of
approximat ely ng L1).
In the oxidation with chlorine, three byproducts were tentatively 
identiﬁed,corresponding toahydroxylation,aromatic substitution of
one hydrogen by chlorine and a decarboxylation/h ydroxylation. The 
oxidation with chlorine dioxide resulted in only one byproduct 
(hydroxylation).
The results of this study have conﬁrmed the need to better under- 
stand the identiﬁcation, occurrence and fate of byproducts of phar- 
maceutical s formed during drinking water treatment and evaluate 
their (eco)toxicological effects. Also future studies on the removal 
of pharmaceuti cals by conventi onal processes combined with non- 
conventi onal processes, such as GAC ﬁltration, ozonation, nanoﬁltra-
tion and oxidative processes must be performed.
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